The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy
source: pixabay.com

The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy

According to an announcement from the Muscular Dystrophy Association, the organization has recently awarded a total of $1,076,232 in MDA Venture Philanthropy (MVP) funding towards the drug company AavantiBio, which…

Continue Reading The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy
Family Sues Prison Officials After “Deliberate Indifference” in Addison’s-Related Death
source: pixabay.com

Family Sues Prison Officials After “Deliberate Indifference” in Addison’s-Related Death

By Rachel Whetstone from In The Cloud Copy Justin Stufflebean was 27 years old when he died after being taken to Missouri Western Reception, Diagnostic and Correctional Center (WRDCC). He…

Continue Reading Family Sues Prison Officials After “Deliberate Indifference” in Addison’s-Related Death
A Woman with Polycystic Kidney Disease Found the Perfect Donor: Her Husband of 51 Years
source: pixabay.com

A Woman with Polycystic Kidney Disease Found the Perfect Donor: Her Husband of 51 Years

By Rachel Whetstone from In The Cloud Copy Peggy Nipper was struggling with polycystic kidney disease (PKD). Her kidneys were beginning to fail after developing numerous cysts. It can often…

Continue Reading A Woman with Polycystic Kidney Disease Found the Perfect Donor: Her Husband of 51 Years
Investigative Therapy for Sickle Cell Disease Receives Rare Pediatric Disease Designation
source: pixabay.com

Investigative Therapy for Sickle Cell Disease Receives Rare Pediatric Disease Designation

Sickle Cell Disease  Sickle cell disease is a rare blood disorder. It is progressive, debilitating, and sadly can be life-threatening. The genetic defect leads patients' red blood cells to be…

Continue Reading Investigative Therapy for Sickle Cell Disease Receives Rare Pediatric Disease Designation
Drugmaker Novartis Launches Lottery for Access to Critical Spinal Muscular Atrophy Treatment
source: pixabay.com

Drugmaker Novartis Launches Lottery for Access to Critical Spinal Muscular Atrophy Treatment

According to a story from euronews.com, the drug maker Novartis has announced that it will give away its breakthrough spinal muscular atrophy gene therapy drug Zolgensma to 100 patients each…

Continue Reading Drugmaker Novartis Launches Lottery for Access to Critical Spinal Muscular Atrophy Treatment